Skip to main content
Premium Trial:

Request an Annual Quote

Randy Goodman

Cancer Genetics has named Randy Goodman its new director of reimbursement and clinical revenue cycle management. He previously served as project director for health economics, reimbursement strategy, and health care policy at Precision for Medicine, and from 2009 to 2011 he was senior director of global health economics and reimbursement strategy at ImpediMed. According to Cancer Genetics, Goodman also served as a healthcare reform policy consultant to the White House Office on Health Reform, and was a policy consultant to Presidents Clinton and Obama.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.